Skip to main content
. 2026 Oct 14;17:1903348. doi: 10.3389/fneur.2026.1903348
Test Best triggers Clinical role Evidence qualification
EEG Fluctuating examination, reduced responsiveness, suspected nonconvulsive seizure, myoclonus, grade ≥2 encephalopathy Distinguish seizure from diffuse encephalopathy and support severity assessment Observational EEG series; selective early use supported, routine universal testing unproven
Selected preinfusion EEG Seizure history, CNS disease, baseline cognitive abnormality, anticipated diagnostic ambiguity Risk context and baseline comparison Single observational adult study; association does not prove clinical benefit
MRI/CT Focal deficit, prolonged or refractory course, concern for stroke, hemorrhage, infection, or edema Exclude structural alternatives Adjunctive diagnostic role; routine imaging in mild ICANS unsupported
CSF Atypical or refractory course with concern for infection, malignant CNS involvement, or competing inflammation Narrow differential diagnosis Selective use based mainly on guidance and clinical reasoning